IT & Industrial Investments

Umana Medical Technologies

Dr Attard Trevisan has successfully developed a medical device called Umana, a new breakthrough in micro technology used in monitoring vital signs whilst allowing the user full flexibility and freedom to enjoy unrestricted day to day lifestyle.

Transcontinental Group is a significant corporate adviser and shareholder in Umana, whilst Dr Attard Trevisan provides consultancy and advisory services to Transcontinental Group’s technological investments.

Neurotech Ltd

TRG entered the IT age at a relatively early stage in Australia with the listing of start up IT Company B2B Ltd. That company eventually made the transition to the Health Tech space and currently trades as Medtech under different management. Mr Trevisan and Transcontinental partnered Dr Adrian Attard Trevisan in the founding creation and development of Neurotech Ltd, an IT company specialising in the the management of autism and related conditions.

Aqua Vital

TRG was instrumental in establishing the Aqua Vital table water business, as an early aggregator of the then-fragmented bottled water market. The business was grown exponentially and ultimately sold, and is now part of Coca Cola’s bottled water business.

Atlas Pearls

TRG’s investment in Atlas South Sea Pearl assisted the company in establishing its operations in Indonesia. Today, the now-named Atlas Pearls and Perfumes is a global leader in eco-pearling, and one of the top producers of the highly sought after silver and white South Sea pearl, with five pearl farms extending through the Indonesian archipelago to West Papua.

Cable Television

TRG was one of the first companies to enter the infancy of cable television industry in Australia. TRG sold it’s interest to Telstra  at an early stage.